# A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

> **NCT07660432** · PHASE1 · RECRUITING · sponsor: **Jiangsu Simcere Pharmaceutical Co., Ltd.** · enrollment: 472 (estimated)

## Conditions studied

- Neoplasms, Malignant

## Interventions

- **DRUG:** SIM0689 for Injection

## Key facts

- **NCT ID:** NCT07660432
- **Lead sponsor:** Jiangsu Simcere Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-03
- **Primary completion:** 2028-12
- **Final completion:** 2029-06
- **Target enrollment:** 472 (ESTIMATED)
- **Last updated:** 2026-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660432, "A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*